<b>Conclusion:</b> Collectively, these findings identify the cooperative action of TOP2 and NOS2 in driving DSBs, highlighting a potential therapeutic target in inflammation-associated CRC. The gene discussed is NOS2; the disease is colorectal carcinoma.